Published 3 days ago • loading... • Updated 2 days ago

John Apathy Joins DataJoint as Strategic Advisor, Strengthening Data and AI Leadership in Life Sciences R&D

Yesterday in Houston, DataJoint announced John Apathy as Strategic Advisor to deepen data and AI leadership across life‑sciences research.
Apathy brings more than 35 years of consulting and technology leadership in biopharma, currently serving as Chief Solutions Officer at XponentL Data, a Genpact company, and formerly at Bristol Myers Squibb.
DataJoint's platform, used by more than 100 research labs including Johns Hopkins, Harvard, UCSF, and UCL, is endorsed by Jim Olson, CEO, who said `His insight and guidance will help us accelerate our growth and expand our impact across the life sciences`.
Apathy's advisory role will focus on computational data integration and reproducibility, aiming to accelerate productivity and discovery across academia and industry research communities.
Following the release from Houston, DataJoint announced via PR Newswire that Apathy said `Digital transformation is accelerating through the application of AI technology in life sciences research and development, and new data and analytical capabilities such as DataJoint are essential to advancing our understanding of complex human biology`.

Insights by Ground AI

22 Articles

abc12/WJRT

+21 Reposted by 21 other sources

Center

John Apathy Joins DataJoint as Strategic Advisor, Strengthening Data and AI Leadership in Life Sciences R&D

HOUSTON, Nov. 12, 2025 /PRNewswire/ -- DataJoint, a leading informatics platform revolutionizing data management and analysis in scientific research and the life sciences sector, today announced the appointment of John Apathy as a Strategic Advisor, deepening the company's expertise in…

3 days ago·Flint, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year